Skip to main content
TipRanks
Go Ultimate75% OFF

Enveric Biosciences (ENVB) Financial Statements

603 Followers

Enveric Biosciences Financial Overview

Enveric Biosciences's market cap is currently $6.04M. The company's EPS TTM is $-6.22; its P/E ratio is -0.22; Enveric Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -200.86K$ -337.49K$ -408.03K$ -435.20K$ -681.61K
Operating Income$ -8.77M$ -9.63M$ -16.45M$ -19.96M$ -25.94M
EBITDA$ -8.57M$ -9.23M$ -16.85M$ -19.52M$ -55.74M
Net Income$ -12.13M$ -9.57M―$ -18.50M$ -48.98M
Balance Sheet
Cash & Short-Term Investments$ 4.68M$ 2.24M$ 2.29M$ 17.72M$ 17.36M
Total Assets$ 5.10M$ 3.08M$ 4.30M$ 19.55M$ 26.72M
Total Debt$ 0.00$ 0.00$ 0.00$ 63.82K$ 176.30K
Net Debt$ -4.68M$ -2.24M$ -2.29M$ -17.66M$ -17.18M
Total Liabilities$ 918.40K$ 1.49M$ 2.34M$ 4.00M$ 4.41M
Stockholders' Equity$ 4.18M$ 1.59M$ 1.96M$ 14.67M$ 22.31M
Cash Flow
Free Cash Flow$ -8.14M$ -7.73M$ -14.10M$ -17.73M$ -12.32M
Operating Cash Flow$ -8.14M$ -7.73M$ -14.09M$ -17.15M$ -11.46M
Investing Cash Flow$ 0.00$ 0.00$ 11.67K$ -584.16K$ 2.19M
Financing Cash Flow$ 10.58M$ 7.67M$ -1.34M$ 18.18M$ 24.90M

Currency in USD

Enveric Biosciences Earnings and Revenue History

-60M060M120M-48 %-36 %-24 %-12 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Enveric Biosciences Liabilities to Assets

020M40M60M0 %25 %50 %75 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Enveric Biosciences Cash Flow

-20M-10M010M20M30M201720182019202020212022202320242025OperatingInvestingFinancing

Enveric Biosciences Forecast EPS vs Actual EPS

-14-12-10-8-6-4-2024Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss